Microbial Restoration in Inflammatory Bowel Diseases
The MIRO II Study: Microbial Restoration in Inflammatory Bowel Diseases
St Vincent's Hospital Melbourne
120 participants
May 1, 2022
INTERVENTIONAL
Conditions
Summary
This is a prospective, two-centre, double-blind, parallel-arm, randomised, placebo-controlled trial evaluating the impact of FMT on patients with active Crohn's disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All patients will receive a one week course of antibiotic therapy.
All patients will be recommended dietary modification 3 weeks prior to, and during, the study.
Anaerobically prepared stool. Dosing will vary according to mode of administration.
Placebo will contain food colourant, 0.9% normal saline and glycerol.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04970446